Abstract
Rarely, inflammatory disorders affect the coronary arteries, as well as the aorta and other large arteries. Giant cell arteritis (GCA), Takayasu’s arteritis (TA), polyarteritis nodosa (PAN), and Kawasaki’s disease (KD) are the major forms of systemic vasculitis that most often target these vessels. However, vasculitis is a much less common cause of coronary artery disease, aortic aneurysm, and large-artery stenosis than atherosclerosis, and the two are often difficult to distinguish from each other based on clinical and imaging findings alone. Vasculitic disorders are usually associated with signs and symptoms of multiorgan system involvement as well as laboratory findings of systemic inflammation, but it is not always the case. For example, a patient with GCA will often present with headache, scalp tenderness, transient visual obscuration, and fatigue and elevated serum levels of acute-phase reactants, while a minority may only present with aortic aneurysm and limb claudication without the typical clinical features. Patients with TA who develop pulseless disease will often have systemic complaints, but others may display only the signs and symptoms related to the involved arteries. Kawasaki’s disease evokes the appropriate suspicion of coronary artery vasculitis in children who present with the typical features of fever, mucocutaneous lesions, and cervical LN enlargement. Atypical clinical presentations, although uncommon, may be more of a diagnostic challenge. While the clinical presentation, laboratory findings, and the results of imaging studies may raise the possibility of systemic vasculitis, the gold standard for diagnosis is tissue histopathology. Therefore, a tissue diagnosis should be pursued if possible. However, tissue biopsy may not be feasible in some cases and the diagnosis reached from the clinical, laboratory, and imaging data alone. Depending on the nature of the disease, treatment usually consists of corticosteroids and other immunosuppressive agents and may include surgical intervention to manage the vascular complications.
Similar content being viewed by others
Abbreviations
- Aneurysm:
-
A localized, blood-filled bulge in the wall of a blood vessel.
- Antineutrophil Cytoplasmic Antibody:
-
An autoantibody directed against antigens in the cytoplasm of neutrophil; often seen in the small vessel vasculitides.
- Antiphospholipid Antibody:
-
An autoantibody directed against anionic phospholipids in plasma membranes; associated with a clotting syndrome of the same name.
- C-Reactive Protein:
-
An acute-phase protein produced by the liver, elevation of which is a marker of systemic inflammation.
- Dendritic Cell:
-
A professional antigen presenting cell of the innate immune system with branched projections (dendrites).
- Erythrocyte Sedimentation Rate:
-
A laboratory test using anticoagulated blood which measures the rate at which red blood cells fall and is measured and reported in mm/h. It is an indirect measure of pro-sedimentation factors such as fibrinogen and immunoglobulins. Increase in the rate at which red cells fall reflects elevation in these factors and is an indirect measure of systemic inflammation.
- Interferon Gamma:
-
A dimerized proinflammatory cytokine which is produced by natural killer cells and Th1 cells.
- Interstitial Keratitis:
-
Corneal scarring due to chronic inflammation of the corneal stoma; seen in a variety of infectious and inflammatory conditions such as syphilis and Cogan syndrome.
- Leukocytoclastic Vasculitis:
-
Cutaneous inflammation of small blood vessels.
- Libman-Sacks Endocarditis:
-
Nonbacterial endocarditis seen in systemic lupus erythematosus.
- Major Histocompatibility Complex:
-
A set of cell surface molecules which bind to and facilitate presentation of antigen to the adaptive immune system.
- Mononeuritis Multiplex:
-
Simultaneous inflammation of noncontiguous nerve trunks affecting at least two separate nerve areas.
- Mucocutaneous Inflammation:
-
Erythema, pain, and sometimes ulceration of the mucosa and surrounds epidermis.
- Multinucleated Giant Cells:
-
A mass formed by the union of distinct cells (usually macrophages).
- Natural Killer Cells:
-
An innate cytotoxic immune cell, involved in killing infected or transformed cells which have downregulated MHC class 1. These cells also participate in the immune response by producing cytokines such as interferon gamma.
- Pulse Steroids:
-
High doses of corticosteroids (0.5–1 g/day) given over several days.
- SLE Disease Activity Index Instrument Score (SLEDAI):
-
A measure of lupus activity used in clinical trials.
- T-Helper Cell:
-
A class of predominantly CD4 positive T cell which is involved directing the immune response.
References
Abdul-Rahman AM, Molteno AC, Bevin TH (2011) The epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysis. N Z Med J 124(1329):44–52
Abe M, Kimura T, Furukawa Y, Tadamura E, Kita T (2007) Coronary Buerger’s disease with a peripheral arterial aneurysm. Eur Heart J 28(8):928. doi:10.1093/eurheartj/ehl314
Agard C, Said L, Ponge T, Connault J, Masseau A, Pistorius MA, Planchon B, Dupas B, Barrier JH, Hamidou MA (2009) Abdominal aortic involvement in active giant cell (temporal) arteritis: a study of 20 patients by Doppler ultrasonography and computed tomographic angiography. Presse Med 38(1):11–19. doi:10.1016/j.lpm.2008.02.016
Akagi T (2011) Catheter interventions for Kawasaki disease: current concepts and future directions. Korean Circ J 41(2):53–57. doi:10.4070/kcj.2011.41.2.53
Akagi T, Ogawa S, Ino T, Iwasa M, Echigo S, Kishida K, Baba K, Matsushima M, Hamaoka K, Tomita H, Ishii M, Kato H (2000) Catheter interventional treatment in Kawasaki disease: a report from the Japanese Pediatric Interventional Cardiology Investigation group. J Pediatr 137(2):181–186. doi:10.1067/mpd.2000.107164
Allsop CJ, Gallagher PJ (1981) Temporal artery biopsy in giant-cell arteritis. A reappraisal. Am J Surg Pathol 5(4):317–323
Amano J, Suzuki A (1991) Coronary artery involvement in Takayasu’s arteritis. Collective review and guideline for surgical treatment. J Thorac Cardiovasc Surg 102(4):554–560
Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134
Arnaud L, Haroche J, Mathian A, Gorochov G, Amoura Z (2011) Pathogenesis of Takayasu’s arteritis: a 2011 update. Autoimmun Rev 11(1):61–67. doi:10.1016/j.autrev.2011.08.001, S1568-9972(11)00171-6 [pii]
Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12):1690–1697. doi:10.1002/art.24092
Baer AZ, Rubin LG, Shapiro CA, Sood SK, Rajan S, Shapir Y, Romano A, Bierman FZ (2006) Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome. Arch Pediatr Adolesc Med 160(7):686–690. doi:10.1001/archpedi.160.7.686
Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69(6):849–858
Bossert M, Prati C, Balblanc JC, Lohse A, Wendling D (2011) Aortic involvement in giant cell arteritis: current data. Joint Bone Spine 78(3):246–251. doi:10.1016/j.jbspin.2010.09.013
Boven K, De Graeff-Meeder ER, Spliet W, Kuis W (1992) Atypical Kawasaki disease: an often missed diagnosis. Eur J Pediatr 151(8):577–580
Branislava I, Marijana T, Nemanja D, Dragan S, Maja Z (2011) Atypical Cogan’s syndrome associated with coronary disease. Chin Med J (Engl) 124(19):3192–3194
Bredemeier M, Rocha CM, Barbosa MV, Pitrez EH (2012) One-year clinical and radiological evolution of a patient with refractory Takayasu’s arteritis under treatment with tocilizumab. Clin Exp Rheumatol 30(1 Suppl 70):S98–100, 5375 [pii]
Breinholt JP 3rd, Tristani-Firouzi M, Bohnsack JF, Shaddy RE (2001) Evidence for early vessel involvement in the dysfunctional myocardium of Takayasu’s arteritis. Pediatr Cardiol 22(1):74–76. doi:10.1007/s002460010160 [pii]
Brueren BR, Ernst JM, Suttorp MJ, ten Berg JM, Rensing BJ, Mast EG, Bal ET, Six AJ, Plokker HW (2003) Long term follow up after elective percutaneous coronary intervention for unprotected non-bifurcational left main stenosis: is it time to change the guidelines? Heart 89(11):1336–1339
Burke MJ, Rennebohm RM, Crowe W, Levinson JE (1981) Follow-up ophthalmologic examinations in children with Kawasaki’s disease. Am J Ophthalmol 91(4):537–539
Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP (1998) Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 17(12):1144–1148
Canpolat C, Dural M, Atalar E (2012) Acute inferior myocardial infarction in a young female patient with polyarteritis nodosa. Herz 37(4):461–463. doi:10.1007/s00059-011-3567-8
Capannari TE, Daniels SR, Meyer RA, Schwartz DC, Kaplan S (1986) Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 7(2):355–360
Carpenter MT, West SG (1994) Polyarteritis nodosa in hairy cell leukemia: treatment with interferon-alpha. J Rheumatol 21(6):1150–1152
Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM (2007) Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum 56(6):2092–2094. doi:10.1002/art.22641
Chan CC, Paine M, O’Day J (2001) Steroid management in giant cell arteritis. Br J Ophthalmol 85(9):1061–1064
Cheung YF, Wong SJ, Ho MH (2007) Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch Dis Child 92(1):43–47. doi:10.1136/adc.2006.096628
Choueiter NF, Olson AK, Shen DD, Portman MA (2010) Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease. J Pediatr 157(6):960–966.e1. doi:10.1016/j.jpeds.2010.06.014
Chu KH, Menapace FJ, Blankenship JC, Hausch R, Harrington T (1998) Polyarteritis nodosa presenting as acute myocardial infarction with coronary dissection. Cathet Cardiovasc Diagn 44(3):320–324
Chung DC, Choi JE, Song YK, Lim AL, Park KH, Choi YJ (2012) Polyarteritis nodosa complicated by chronic total occlusion accompanying aneurysms on all coronary arteries. Korean Circ J 42(8):568–570. doi:10.4070/kcj.2012.42.8.568
Cochrane AD, Tatoulis J (1991) Cogan’s syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenoses. Ann Thorac Surg 52(5):1166–1167
Cohen Tervaert JW (2013) Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides. Best Pract Res Clin Rheumatol 27(1):33–44. doi:10.1016/j.berh.2012.12.004
Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z, Cacoub P, Saadoun D (2012) Anti TNF-alpha in refractory Takayasu’s arteritis: cases series and review of the literature. Autoimmun Rev 11(9):678–684. doi:10.1016/j.autrev.2011.11.025, S1568-9972(11)00299-0 [pii]
Comarmond C, Pagnoux C, Khellaf M, Cordier JF, Hamidou M, Viallard JF, Maurier F, Jouneau S, Bienvenu B, Puechal X, Aumaitre O, Le Guenno G, Le Quellec A, Cevallos R, Fain O, Godeau B, Seror R, Dunogue B, Mahr A, Guilpain P, Cohen P, Aouba A, Mouthon L, Guillevin L (2013) Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65(1):270–281. doi:10.1002/art.37721
Cremer J, Laas J, Heublein B (1993) A case of coronary stenosis developing after successful aortic valve repair in Cogan’s syndrome. Thorac Cardiovasc Surg 41(4):255–257. doi:10.1055/s-2007-1013866
Danias PG, Stuber M, Botnar RM, Kissinger KV, Yeon SB, Rofsky NM, Manning WJ (2003) Coronary MR angiography clinical applications and potential for imaging coronary artery disease. Magn Reson Imaging Clin N Am 11(1):81–99
Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM (2010) Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 121(7):906–915. doi:10.1161/CIRCULATIONAHA.109.872903, CIRCULATIONAHA.109.872903 [pii]
Devauchelle-Pensec V, Jousse S, Destombe C, Saraux A (2008) Epidemiology, imaging, and treatment of giant cell arteritis. Joint Bone Spine 75(3):267–272. doi:10.1016/j.jbspin.2007.09.008, S1297-319X(08)00029-8 [pii]
Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M (2005) Cardiac involvement in systemic lupus erythematosus. Lupus 14(9):683–686
Drossner DM, Chappell C, Rab T, Kim D (2012) Percutaneous coronary intervention for acute myocardial infarction in a pediatric patient with coronary aneurysm and stenosis due to Kawasaki disease. Pediatr Cardiol 33(5):811–813. doi:10.1007/s00246-012-0190-2
Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96(6):1057–1061
Endo M, Tomizawa Y, Nishida H, Aomi S, Nakazawa M, Tsurumi Y, Kawana M, Kasanuki H (2003) Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg 125(3):570–577. doi:10.1067/mtc.2003.39 S0022522302732868 [pii]
Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senecal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331–2337
Evans JM, Bowles CA, Bjornsson J, Mullany CJ, Hunder GG (1994) Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 37(10):1539–1547
Evans JM, O’Fallon WM, Hunder GG (1995) Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 122(7):502–507
Freddo T, Price M, Kase C, Goldstein MP (1999) Myocardial infarction and coronary artery involvement in giant cell arteritis. Optom Vis Sci 76(1):14–18
Frohnert PP, Sheps SG (1967) Long-term follow-up study of periarteritis nodosa. Am J Med 43(1):8–14
Frustaci A, Gentiloni N, Chimenti C, Natale L, Gasbarrini G, Maseri A (1998) Necrotizing myocardial vasculitis in Churg-Strauss syndrome: clinicohistologic evaluation of steroids and immunosuppressive therapy. Chest 114(5):1484–1489
Fujiwara T, Fujiwara H, Hamashima Y (1987) Size of coronary aneurysm as a determinant factor of the prognosis in Kawasaki disease: clinicopathologic study of coronary aneurysms. Prog Clin Biol Res 250:519–520
Furst DE, Clarke AE, Fernandes AW, Bancroft T, Greth W, Iorga SR (2013) Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population. Lupus 22(1):99–105. doi:10.1177/0961203312463110
Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K (1992) Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum. Eur J Pediatr 151(1):44–47
Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T et al (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2(8411):1055–1058
Galve E, Candellriera J, Pigrau C, Permanyermiralda G, Garciadelcastillo H, Solersoler J (1988) Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus-erythematosus. New Engl J Med 319(13):817–823. doi:10.1056/Nejm198809293191302
Garcia Vazquez JM, Carreira JM, Seoane C, Vidal JJ (1999) Superior and inferior limb ischaemia in giant cell arteritis: angiography follow-up. Clin Rheumatol 18(1):61–65
Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B (2001) Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 44(3):666–675. doi:10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A
Godoy P, Araujo Sde A, Paulino E Jr, Lana-Peixoto MA (2007) Coronary giant cell arteritis and acute myocardial infarction. Arq Bras Cardiol 88(4):e84–87, S0066-782X2007000400027 [pii]
Gong GW, McCrindle BW, Ching JC, Yeung RS (2006) Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr 148(6):800–805. doi:10.1016/j.jpeds.2006.01.039
Gonzalez-Gay MA, Rodriguez-Valverde V (2010) Vasculitis syndromes: Not losing sight is the issue in GCA management. Nat Rev Rheumatol 6(8):440–441. doi:10.1038/nrrheum.2010.119, nrrheum.2010.119 [pii]
Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG (2004) Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 83(6):335–341
Goodwin JS (1992) Progress in gerontology: polymyalgia rheumatica and temporal arteritis. J Am Geriatr Soc 40(5):515–525
Grasland A, Pouchot J, Hachulla E, Bletry O, Papo T, Vinceneux P (2004) Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 43(8):1007–1015. doi:10.1093/rheumatology/keh228
Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, Manning WJ, Powell AJ (2002) Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation 105(8):908–911
Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75(1):17–28
Guillevin L, Mahr A, Callard P, Godmer P, Pagnoux C, Leray E, Cohen P (2005) Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84(5):313–322
Gulati A, Bagga A (2010) Large vessel vasculitis. Pediatr Nephrol 25(6):1037–1048. doi:10.1007/s00467-009-1312-9
Haberhauer G, Kittl EM, Dunky A, Feyertag J, Bauer K (2001) Beneficial effects of leflunomide in glucocorticoid- and methotrexate-resistant Takayasu’s arteritis. Clin Exp Rheumatol 19(4):477–478
Hammer M, Witte T, Mugge A, Wollenhaupt J, Laas J, Laszig R, Zeidler H (1994) Complicated Cogan’s syndrome with aortic insufficiency and coronary stenosis. J Rheumatol 21(3):552–555
Hara T, Yamaguchi K, Iwase T, Kadota M, Bando M, Ogasawara K, Bando S, Ise T, Niki T, Ueda Y, Tomita N, Taketani Y, Yamada H, Soeki T, Wakatsuki T, Sata M (2013) Eosinophilic myocarditis due to Churg-Strauss syndrome with markedly elevated eosinophil cationic protein. Int Heart J 54(1):51–53
Harada M, Yokouchi Y, Oharaseki T, Matsui K, Tobayama H, Tanaka N, Akimoto K, Takahashi K, Kishiro M, Shimizu T (2012) Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology 61(6):1156–1167. doi:10.1111/j.1365-2559.2012.04332.x
Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–163, 0167527396026514 [pii]. Results of a conference establish a new agiographic classification scheme for TA
Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnsen V (1998) Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol 17(5):364–368
Haugeberg G, Paulsen PQ, Bie RB (2000) Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 27(11):2624–2627
Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS (1980) Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 59(6):426–441
Hayreh SS, Zimmerman B, Kardon RH (2002) Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand 80(4):355–367, aos800403 [pii]
Heno P, Fourcade L, N’Guyen Duc H, Flin C, N’Guyen Huy Thuy G, Chalvidan T, Mafart B, Touze JE (2000) Buerger’s disease and coronary disease. Arch Mal Coeur Vaiss 93(10):1239–1242
Hicks RV, Melish ME (1986) Kawasaki syndrome. Pediatr Clin North Am 33(5):1151–1175
Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, Cohen P, Calabrese LH, Dickler H, Merkel PA, Fortin P, Flynn JA, Locker GA, Easley KA, Schned E, Hunder GG, Sneller MC, Tuggle C, Swanson H, Hernandez-Rodriguez J, Lopez-Soto A, Bork D, Hoffman DB, Kalunian K, Klashman D, Wilke WS, Scheetz RJ, Mandell BF, Fessler BJ, Kosmorsky G, Prayson R, Luqmani RA, Nuki G, McRorie E, Sherrer Y, Baca S, Walsh B, Ferland D, Soubrier M, Choi HK, Gross W, Segal AM, Ludivico C, Puechal X (2002) A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 46(5):1309–1318. doi:10.1002/art.10262
Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB (2010a) Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007. Pediatr Infect Dis J 29(6):483–488. doi:10.1097/INF.0b013e3181cf8705
Holman RC, Christensen KY, Belay ED, Steiner CA, Effler PV, Miyamura J, Forbes S, Schonberger LB, Melish M (2010b) Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J 69(8):194–197
Holsinger DR, Osmundson PJ, Edwards JE (1962) The heart in periarteritis nodosa. Circulation 25:610–618
Hong TE, Faxon DP (2005) Coronary artery disease in patients with Buerger’s disease. Rev Cardiovasc Med 6(4):222–226
Hui-Yuen JS, Duong TT, Yeung RS (2006) TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 176(10):6294–6301
Hunder GG, Sheps SG, Allen GL, Joyce JW (1975) Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med 82(5):613–618
Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33(8):1122–1128
Hupp SL, Nelson GA, Zimmerman LE (1990) Generalized giant-cell arteritis with coronary artery involvement and myocardial infarction. Arch Ophthalmol 108(10):1385–1387
Ichiyama T, Yoshitomi T, Nishikawa M, Fujiwara M, Matsubara T, Hayashi T, Furukawa S (2001) NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease. Clin Immunol 99(3):373–377. doi:10.1006/clim.2001.5026
Innala L, Moller B, Ljung L, Magnusson S, Smedby T, Sodergren A, Ohman ML, Rantapaa-Dahlqvist S, Wallberg-Jonsson S (2011) Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 13(4):R131. doi:10.1186/ar3442
Ishii M, Ueno T, Akagi T, Baba K, Harada K, Hamaoka K, Kato H, Tsuda E, Uemura S, Saji T, Ogawa S, Echigo S, Yamaguchi T (2001) Guidelines for catheter intervention in coronary artery lesion in Kawasaki disease. Pediatr Int 43(5):558–562
Ishii M, Ueno T, Ikeda H, Iemura M, Sugimura T, Furui J, Sugahara Y, Muta H, Akagi T, Nomura Y, Homma T, Yokoi H, Nobuyoshi M, Matsuishi T, Kato H (2002) Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 105(25):3004–3010
Isohisa I, Numano F, Maezawa H, Sasazuki T (1978) HLA-Bw52 in Takayasu disease. Tissue Antigens 12(4):246–248
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11. doi:10.1002/art.37715. A key reference for the new nomenclature of systemic vasculitis
Josselin-Mahr L, El Hessen TA, Toledano C, Fardet L, Kettaneh A, Tiev K, Cabane J (2013) Inflammatory aortitis in giant cell arteritis. Presse Med 42(2):151–159. doi:10.1016/j.lpm.2012.03.003
Jover JA, Hernandez-Garcia C, Morado IC, Vargas E, Banares A, Fernandez-Gutierrez B (2001) Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial. Ann Intern Med 134(2):106–114, 200101160–00010 [pii]
Kahlenberg JM, Kaplan MJ (2013) Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus. Annu Rev Med 64:249–263. doi:10.1146/annurev-med-060911-090007
Kaiser M, Younge B, Bjornsson J, Goronzy JJ, Weyand CM (1999) Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am J Pathol 155(3):765–774. doi:10.1016/S0002-9440(10)65175-9, S0002-9440(10)65175-9 [pii]
Karger B, Fechner G (2006) Sudden death due to giant cell coronary arteritis. Int J Legal Med 120(6):377–379. doi:10.1007/s00414-006-0090-1
Kastner D, Gaffney M, Tak T (2000) Polyarteritis nodosa and myocardial infarction. Can J Cardiol 16(4):515–518
Kato H, Ichinose E, Kawasaki T (1986) Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr 108(6):923–927
Kato H, Inoue O, Ichinose E, Akagi T, Sato N (1991) Intracoronary urokinase in Kawasaki disease: treatment and prevention of myocardial infarction. Acta Paediatr Jpn 33(1):27–35
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94(6):1379–1385
Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929
Kim JS, Park JB, Joo JC, Seol MD, Yoon JW, Park HK, Won DJ, Cho WH (2010) A case of Cogan’s syndrome with angina. Korean Circ J 40(12):680–683. doi:10.4070/kcj.2010.40.12.680
Kimura T, Miyazawa H, Watanabe K, Moriya T (1988) Small pustules in Kawasaki disease. A clinicopathological study of four patients. Am J Dermatopathol 10(3):218–223
Kimura T, Komura M, Okubo Y (2012) Atypical giant cell arteritis predominantly involving intramural coronary arteries: a case showing refractory dialysis-related hypotension. Heart Vessels 27(2):216–220. doi:10.1007/s00380-011-0158-9
Kitamura S, Kameda Y, Seki T, Kawachi K, Endo M, Takeuchi Y, Kawasaki T, Kawashima Y (1994) Long-term outcome of myocardial revascularization in patients with Kawasaki coronary artery disease. A multicenter cooperative study. J Thorac Cardiovasc Surg 107(3):663–673, discussion 673–664
Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113(22):2606–2612. doi:10.1161/CIRCULATIONAHA.105.592865
Kobayashi H, Yokoe I, Hattan N, Ohta H, Nakajima Y, Kobayashi Y (2010) Cardiac magnetic resonance imaging in polyarteritis nodosa. J Rheumatol 37(11):2427–2429. doi:10.3899/jrheum.100450
Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse S, Ichida F, Seki M, Fukazawa R, Ogawa C, Furuno K, Tokunaga H, Takatsuki S, Hara S, Morikawa A (2012) Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 379(9826):1613–1620. doi:10.1016/S0140-6736(11)61930-2
Koivuniemi R, Paimela L, Suomalainen R, Tornroth T, Leirisalo-Repo M (2008) Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid Int J Exp Clin Invest Official J Int Soc Amyloid 15(4):262–268. doi:10.1080/13506120802524676
Kumar P, Velissaris T, Sheppard MN, Pepper JR (2002) Giant cell arteritis confined to intramural coronary arteries. Unforeseen hazards myocardial protection. J Cardiovasc Surg (Torino) 43(5):647–649
Kussmaul A, Matteson EL, Kussmaul A, Maier R (1996) On a previous undescribed peculiar arterial disease (Periarteritis nodosa), accompanied by Bright’s disease and rapidly progressive general muscle weakness. Mayo Foundation, Rochester. English translation of the classic article describing what we now call PAN
Langford CA, Sneller MC, Hoffman GS (1997) Methotrexate use in systemic vasculitis. Rheum Dis Clin North Am 23(4):841–853
Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, Heyse SP, Hirsch R, Hochberg MC, Hunder GG, Liang MH, Pillemer SR, Steen VD, Wolfe F (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41(5):778–799. doi:10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V
Le Hello C, Levesque H, Jeanton M, Cailleux N, Galateau F, Peillon C, Veyssier P, Watelet J, Letellier P, Courtois H, Maiza D (2001) Lower limb giant cell arteritis and temporal arteritis: followup of 8 cases. J Rheumatol 28(6):1407–1412
Lebowitz WB (1963) The heart in rheumatoid arthritis (rheumatoid disease). A clinical and pathological study of sixty-two cases. Ann Intern Med 58:102–123
Lee HY, Rao PS (1996) Percutaneous transluminal coronary angioplasty in Takayasu’s arteritis. Am Heart J 132(5):1084–1086, S0002-8703(96)90036-8 [pii]
Lee JL, Naguwa SM, Cheema GS, Gershwin ME (2009) Revisiting Libman-Sacks endocarditis: a historical review and update. Clin Rev Allergy Immunol 36(2–3):126–130. doi:10.1007/s12016-008-8113-y
Leib ES, Restivo C, Paulus HE (1979) Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 67(6):941–947
Leung WH, Wong KL, Lau CP, Wong CK, Cheng CH (1990) Cardiac abnormalities in systemic lupus erythematosus: a prospective M-mode, cross-sectional and Doppler echocardiographic study. Int J Cardiol 27(3):367–375
Libman E, Sacks B (1924) A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 33(6):701–737
Lie JT (1978) Disseminated visceral giant cell arteritis: histopathologic description and differentiation from other granulomatous vasculitides. Am J Clin Pathol 69(3):299–305
Lie JT (1998) Pathology of isolated nonclassical and catastrophic manifestations of Takayasu arteritis. Int J Cardiol 66(Suppl 1):S11–S21
Lin LW, Wang SS, Shun CT (2007) Myocardial infarction due to giant cell arteritis: a case report and literature review. Kaohsiung J Med Sci 23(4):195–198. doi:10.1016/S1607-551X(09)70397-3, S1607-551X(09)70397-3 [pii]
Livingston JZ, Casale AS, Hutchins GM, Shapiro EP (1992) Coronary involvement in Cogan’s syndrome. Am Heart J 123(2):528–530
Luca NJ, Yeung RS (2012) Epidemiology and management of Kawasaki disease. Drugs 72(8):1029–1038. doi:10.2165/11631440-000000000-00000
Lupi-Herrera E, Sanchez-Torres G, Marcushamer J, Mispireta J, Horwitz S, Vela JE (1977) Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 93(1):94–103
Mackie SL, Hensor EM, Morgan AW, Pease CT (2012) Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis. Ann Rheum Dis. doi:10.1136/annrheumdis-2012-202145, annrheumdis-2012-202145 [pii]
Magder LS, Petri M (2012) Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus. Am J Epidemiol 176(8):708–719. doi:10.1093/aje/kws130
Mahr A, Guillevin L, Poissonnet M, Ayme S (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener’s granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 51(1):92–99. doi:10.1002/art.20077
Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2007) Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 56(3):1000–1009. doi:10.1002/art.22404
Maksimowicz-McKinnon K, Clark TM, Hoffman GS (2009) Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? Medicine (Baltimore) 88(4):221–226. doi:10.1097/MD.0b013e3181af70c1 00005792-200907000-00005 [pii]
Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D’Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145(5):408–415
Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52(3):722–732. doi:10.1002/art.20878
Marie I, Proux A, Duhaut P, Primard E, Lahaxe L, Girszyn N, Louvel JP, Levesque H (2009) Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine (Baltimore) 88(3):182–192. doi:10.1097/MD.0b013e3181a68ae2
Marla R, Ebel R, Crosby M, Almassi GH (2009) Multiple giant coronary artery aneurysms. Tex Heart Inst J 36(3):244–246
Martin JF, Kittas C, Triger DR (1980) Giant cell arteritis of coronary arteries causing myocardial infarction. Br Heart J 43(4):487–489
Marzano AV, Vezzoli P, Berti E (2013) Skin involvement in cutaneous and systemic vasculitis. Autoimmun Rev 12(4):467–476. doi:10.1016/j.autrev.2012.08.005
Matsubara T, Ichiyama T, Furukawa S (2005) Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease. Clin Exp Immunol 141(3):381–387. doi:10.1111/j.1365-2249.2005.02821.x
Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, Cokkinos DV, Moutsopoulos HM (2009a) Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum 61(8):1121–1129. doi:10.1002/art.24695
Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV (2009b) Cardiovascular magnetic resonance imaging reveals myocardial inflammation and coronary artery ectasia during the acute phase of Kawasaki disease. Int J Cardiol 136(3):e51–e53. doi:10.1016/j.ijcard.2008.05.005
McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP (1989) Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 9(1):97–101
McNeal-Davidson A, Fournier A, Scuccimarri R, Dancea A, Houde C, Bellavance M, Dahdah N (2013) The fate and observed management of giant coronary artery aneurysms secondary to Kawasaki disease in the Province of Quebec: the complete series since 1976. Pediatr Cardiol 34(1):170–178. doi:10.1007/s00246-012-0409-2
McWilliams ET, Khonizy W, Jameel A (2013) Polyarteritis nodosa presenting as acute myocardial infarction in a young man: importance of invasive angiography. Heart. doi:10.1136/heartjnl-2013-304022
Mehra NK, Jaini R, Balamurugan A, Kanga U, Prabhakaran D, Jain S, Talwar KK, Sharma BK (1998) Immunogenetic analysis of Takayasu arteritis in Indian patients. Int J Cardiol 66(Suppl 1):S127–132, discussion S133
Mekinian A, Neel A, Sibilia J, Cohen P, Connault J, Lambert M, Federici L, Berthier S, Fiessinger JN, Godeau B, Marie I, Guillevin L, Hamidou M, Fain O (2012) Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study. Rheumatology (Oxford) 51(5):882–886, ker380 [pii] 10.1093/rheumatology/ker380
Min PK, Park S, Jung JH, Ko YG, Choi D, Jang Y, Shim WH (2005) Endovascular therapy combined with immunosuppressive treatment for occlusive arterial disease in patients with Takayasu’s arteritis. J Endovasc Ther 12(1):28–34. doi:10.1583/12-01-04-1329.1, 12-01-04-1329 [pii]
Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M (2009) Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 48(12):1560–1565. doi:10.1093/rheumatology/kep304
Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS (2008) Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 67(11):1567–1569. doi:10.1136/ard.2008.093260, ard.2008.093260 [pii]
Morita T, Kamimura A, Koizumi F (1987) Disseminated visceral giant cell arteritis. Acta Pathol Jpn 37(5):863–870
Morris CR, Scheib JS (1994) Fatal myocardial infarction resulting from coronary arteritis in a patient with polymyalgia rheumatica and biopsy-proved temporal arteritis. A case report and review of the literature. Arch Intern Med 154(10):1158–1160
Morrison AN, Abitbol M (1955) Granulomatous arteritis with myocardial infarction: a case report with autopsy findings. Ann Intern Med 42(3):691–700
Moyssakis I, Tektonidou MG, Vasilliou VA, Samarkos M, Votteas V, Moutsopoulos HM (2007) Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med 120(7):636–642. doi:10.1016/j.amjmed.2007.01.024
Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R (2009) EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68(3):318–323. doi:10.1136/ard.2008.088351, ard.2008.088351 [pii]. An up to date review on recommendations for management of GCA and TA
Muta H, Ishii M (2010) Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. J Pediatr 157(1):120–126. doi:10.1016/j.jpeds.2010.01.032
Nakamura T (2008) Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis. Mod Rheumatol 18(2):109–118. doi:10.1007/s10165-008-0035-2
Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, Ojima T, Sonobe T, Yanagawa H (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46(1):33–38. doi:10.1111/j.1442-200X.2004.01840.x
Nakamura Y, Yashiro M, Uehara R, Sadakane A, Tsuboi S, Aoyama Y, Kotani K, Tsogzolbaatar EO, Yanagawa H (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol 22(3):216–221
Nakano H, Ueda K, Saito A, Nojima K (1985) Repeated quantitative angiograms in coronary arterial aneurysm in Kawasaki disease. Am J Cardiol 56(13):846–851
Nesher G, Berkun Y, Mates M, Baras M, Rubinow A, Sonnenblick M (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50(4):1332–1337. doi:10.1002/art.20171
Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, Reinhardt D, Wolf G, Hein G, Mall G, Schett G, Zwerina J (2009) Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) 88(4):236–243. doi:10.1097/MD.0b013e3181af35a5
Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324(23):1633–1639. doi:10.1056/NEJM199106063242305
Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110(17):2747–2771. doi:10.1161/01.CIR.0000145143.19711.78. Recommendations for the diagnosis, treatment and management of Kawasaki’s disease
Nishimoto N, Nakahara H, Yoshio-Hoshino N, Mima T (2008) Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody. Arthritis Rheum 58(4):1197–1200. doi:10.1002/art.23373
Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, Sumitomo N, Harada K (2001) Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107(5):1095–1099
Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL (2003) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48(12):3522–3531. doi:10.1002/art.11353
Numano F (1997) Differences in clinical presentation and outcome in different countries for Takayasu’s arteritis. Curr Opin Rheumatol 9(1):12–15
O’Brien PK, Pudden AJ (1978) Peripheral arterial insufficiency due to giant cell arteritis. Can J Surg 21(5):441–442
Odhav S, McKown K, Lohr KM (1994) Polyarteritis nodosa presenting as recurrent myocardial infarction. Chest 105(5):1615
Orenstein JM, Shulman ST, Fox LM, Baker SC, Takahashi M, Bhatti TR, Russo PA, Mierau GW, de Chadarevian JP, Perlman EJ, Trevenen C, Rotta AT, Kalelkar MB, Rowley AH (2012) Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study. PLoS One 7(6):e38998. doi:10.1371/journal.pone.0038998
Ormerod AS, Cook MC (2008) Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales. Intern Med J 38(11):816–823. doi:10.1111/j.1445-5994.2008.01672.x
Ozdemir H, Ciftci E, Tapisiz A, Ince E, Tutar E, Atalay S, Dogru U (2010) Clinical and epidemiological characteristics of children with Kawasaki disease in Turkey. J Trop Pediatr 56(4):260–262. doi:10.1093/tropej/fmp110
Pagnoux C, Guillevin L (2005) Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol 17(1):41–48
Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, Bienvenu B, Mouthon L, Guillevin L (2010) Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the French Vasculitis Study Group Database. Arthritis Rheum 62(2):616–626. doi:10.1002/art.27240
Park MH, Park YB (1992) HLA typing of Takayasu arteritis in Korea. Heart Vessels Suppl 7:81–84
Park YB, Hong SK, Choi KJ, Sohn DW, Oh BH, Lee MM, Choi YS, Seo JD, Lee YW, Park JH (1992) Takayasu arteritis in Korea: clinical and angiographic features. Heart Vessels Suppl 7:55–59
Paulley JW (1980) Coronary ischaemia and occlusion in giant cell (temporal) arteritis. Acta Med Scand 208(4):257–263
Paulley JW, Hughes JP (1960) Giant-cell arteritis, or arteritis of the aged. Br Med J 2(5212):1562–1567. A classic article on GCA. One of the first to identify angina pectoralis and myocardial infarction as a consequence of the disease
Pick RA, Glover MU, Vieweg WV (1982) Myocardial infarction in a young woman with isolated coronary arteritis. Chest 82(3):378–380
Pipitone N, Salvarani C (2008) Role of imaging in vasculitis and connective tissue diseases. Best Pract Res Clin Rheumatol 22(6):1075–1091. doi:10.1016/j.berh.2008.09.015, S1521-6942(08)00112-5 [pii]
Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS (2010) Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum 39(4):257–268. doi:10.1016/j.semarthrit.2008.10.007
Portman MA, Olson A, Soriano B, Dahdah N, Williams R, Kirkpatrick E (2011) Etanercept as adjunctive treatment for acute Kawasaki disease: study design and rationale. Am Heart J 161(3):494–499. doi:10.1016/j.ahj.2010.12.003
Przybojewski JZ (1981) Polyarteritis nodosa in the adult. Report of a case with repeated myocardial infarction and a review of cardiac involvement. S Afr Med J 60(13):512–518
Punamiya K, Bates ER, Shea MJ, Muller DW (1997) Endoluminal stenting for unprotected left main stenosis in Takayasu’s arteritis. Cathet Cardiovasc Diagn 40(3):272–275. doi:10.1002/(SICI)1097-0304(199703)40:3<272::AID-CCD11>3.0.CO;2-R [pii]
Ramos-Casals M, Munoz S, Medina F, Jara LJ, Rosas J, Calvo-Alen J, Brito-Zeron P, Forns X, Sanchez-Tapias JM (2009) Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry). J Rheumatol 36(7):1442–1448. doi:10.3899/jrheum.080874
Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL (2000) Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany. Rheumatology (Oxford) 39(12):1396–1402
Rennebohm RM, Burke MJ, Crowe W, Levinson JE (1981) Anterior uveitis in Kawasaki’s disease. Am J Ophthalmol 91(4):535–537
Resnick SD (1997) New aspects of exanthematous diseases of childhood. Dermatol Clin 15(2):257–266
Ribi C, Cohen P, Pagnoux C, Mahr A, Arene JP, Puechal X, Carli P, Kyndt X, Le Hello C, Letellier P, Cordier JF, Guillevin L (2010) Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: a prospective randomized study of one hundred twenty-four patients. Arthritis Rheum 62(4):1186–1197. doi:10.1002/art.27340
Richards BL, March L, Gabriel SE (2010) Epidemiology of large-vessel vasculidities. Best Pract Res Clin Rheumatol 24(6):871–883. doi:10.1016/j.berh.2010.10.008, S1521-6942(10)00094-X [pii]
Rittner HL, Kaiser M, Brack A, Szweda LI, Goronzy JJ, Weyand CM (1999) Tissue-destructive macrophages in giant cell arteritis. Circ Res 84(9):1050–1058
Rodriguez-Pla A, Bosch-Gil JA, Rossello-Urgell J, Huguet-Redecilla P, Stone JH, Vilardell-Tarres M (2005) Metalloproteinase-2 and -9 in giant cell arteritis: involvement in vascular remodeling. Circulation 112(2):264–269. doi:10.1161/CIRCULATIONAHA.104.520114, CIRCULATIONAHA.104.520114 [pii]
Rojo-Leyva F, Ratliff NB, Cosgrove DM 3rd, Hoffman GS (2000) Study of 52 patients with idiopathic aortitis from a cohort of 1,204 surgical cases. Arthritis Rheum 43(4):901–907. doi:10.1002/1529-0131(200004)43:4<901::AID-ANR23>3.0.CO;2-U
Roldan CA (1998) Valvular disease associated with systemic illness. Cardiol Clin 16(3):531–550
Rose AG, Sinclair-Smith CC (1980) Takayasu’s arteritis. A study of 16 autopsy cases. Arch Pathol Lab Med 104(5):231–237
Rowley AH, Shulman ST (1999) Kawasaki syndrome. Pediatr Clin North Am 46(2):313–329
Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST (1987) Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 110(3):409–413
Salvarani C, Gabriel SE, O’Fallon WM, Hunder GG (1995) The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123(3):192–194
Salvarani C, Cantini F, Boiardi L, Hunder GG (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347(4):261–271. doi:10.1056/NEJMra011913 347/4/261 [pii]
Salvarani C, Crowson CS, O’Fallon WM, Hunder GG, Gabriel SE (2004) Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 51(2):264–268. doi:10.1002/art.20227
Salvarani C, Magnani L, Catanoso M, Pipitone N, Versari A, Dardani L, Pulsatelli L, Meliconi R, Boiardi L (2012a) Tocilizumab: a novel therapy for patients with large-vessel vasculitis. Rheumatology (Oxford) 51(1):151–156. doi:10.1093/rheumatology/ker296, ker296 [pii]
Salvarani C, Magnani L, Catanoso MG, Pipitone N, Versari A, Dardani L, Pulsatelli L, Meliconi R, Boiardi L (2012b) Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-alpha blockers. Clin Exp Rheumatol 30(1 Suppl 70):S90–S93
Schmidt WA (2004) Use of imaging studies in the diagnosis of vasculitis. Curr Rheumatol Rep 6(3):203–211
Schmidt WA, Blockmans D (2005) Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 17(1):9–15
Schrader ML, Hochman JS, Bulkley BH (1985) The heart in polyarteritis nodosa: a clinicopathologic study. Am Heart J 109(6):1353–1359
Scott DG, Bacon PA (1984) Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med 76(3):377–384
Seitz M, Reichenbach S, Bonel HM, Adler S, Wermelinger F, Villiger PM (2011) Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series. Swiss Med Wkly 141:w13156. doi:10.4414/smw.2011.13156, smw-13156 [pii]
Seko Y, Minota S, Kawasaki A, Shinkai Y, Maeda K, Yagita H, Okumura K, Sato O, Takagi A, Tada Y et al (1994) Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu’s arteritis. J Clin Invest 93(2):750–758. doi:10.1172/JCI117029
Sharma BK, Jain S, Radotra BD (1998) An autopsy study of Takayasu arteritis in India. Int J Cardiol 66(Suppl 1):S85–90, discussion S91
Sharma BK, Jain S, Bali HK, Jain A, Kumari S (2000) A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 75(Suppl 1):S147–152, S0167527300001923 [pii]
Shelhamer JH, Volkman DJ, Parrillo JE, Lawley TJ, Johnston MR, Fauci AS (1985) Takayasu’s arteritis and its therapy. Ann Intern Med 103(1):121–126
Silman AJ, Hochberg MC (2001) Epidemiology of the rheumatic diseases, 2nd edn, Oxford medical publications. Oxford University Press, Oxford/New York
Smetana GW, Shmerling RH (2002) Does this patient have temporal arteritis? JAMA 287(1):92–101. Article aimed at generalist on the diagnosis of Giant Cell Arteritis. Includes likelihood ratios for a variety of features
Sohn S, Kim HS, Lee SW (2004) Multidetector row computed tomography for follow-up of patients with coronary artery aneurysms due to Kawasaki disease. Pediatr Cardiol 25(1):35–39. doi:10.1007/s00246-003-0559-3
Son MB, Gauvreau K, Burns JC, Corinaldesi E, Tremoulet AH, Watson VE, Baker A, Fulton DR, Sundel RP, Newburger JW (2011) Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study. J Pediatr 158(4):644–649.e1. doi:10.1016/j.jpeds.2010.10.012
Sonnenblick M, Nesher G, Friedlander Y, Rubinow A (1994) Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 33(10):938–941
Spiera RF, Mitnick HJ, Kupersmith M, Richmond M, Spiera H, Peterson MG, Paget SA (2001) A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA). Clin Exp Rheumatol 19(5):495–501
Srinivasan G, Boschman C, Roth SI, Hendel RC (1997) Unsuspected vasculitis and intracranial hemorrhage following thrombolysis. Clin Cardiol 20(1):84–86
Stacy RC, Rizzo JF, Cestari DM (2011) Subtleties in the histopathology of giant cell arteritis. Semin Ophthalmol 26(4–5):342–348. doi:10.3109/08820538.2011.588656
Stone JH (2002) Polyarteritis nodosa. JAMA 288(13):1632–1639. Review of clinical features of PAN
Sugahara Y, Ishii M, Muta H, Iemura M, Matsuishi T, Kato H (2008) Warfarin therapy for giant aneurysm prevents myocardial infarction in Kawasaki disease. Pediatr Cardiol 29(2):398–401. doi:10.1007/s00246-007-9132-9
Sugihara N, Genda A, Shimizu M, Suematsu T, Kita Y, Shimizu K, Takeda R (1990) Intramural coronary angiitis of periarteritis nodosa proved by endomyocardial biopsy. Am Heart J 119(6):1414–1416
Sugimura T, Yokoi H, Sato N, Akagi T, Kimura T, Iemura M, Nobuyoshi M, Kato H (1997) Interventional treatment for children with severe coronary artery stenosis with calcification after long-term Kawasaki disease. Circulation 96(11):3928–3933
Sugiura T, Kumon Y, Kataoka H, Matsumura Y, Takeuchi H, Doi YL (2009) Asymptomatic pericardial effusion in patients with systemic lupus erythematosus. Lupus 18(2):128–132. doi:10.1177/0961203308094763
Takahashi M, Mason W, Lewis AB (1987) Regression of coronary aneurysms in patients with Kawasaki syndrome. Circulation 75(2):387–394
Tanaka F, Kawakami A, Iwanaga N, Tamai M, Izumi Y, Aratake K, Arima K, Kamachi M, Nakamura H, Huang M, Ida H, Origuchi T, Eguchi K (2006) Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexate. Intern Med 45(5):313–316, JST.JSTAGE/internalmedicine/45.1377 [pii]
Tasdemir I, Turgan C, Emri S, Yasavul U, Caglar S, Bakkaloglu M, Erkan I, Erol D (1988) Spontaneous perirenal haematoma secondary to polyarteritis nodosa. Br J Urol 62(3):219–222
Tato F, Hoffmann U (2006) Clinical presentation and vascular imaging in giant cell arteritis of the femoropopliteal and tibioperoneal arteries. Analysis of four cases. J Vasc Surg 44(1):176–182. doi:10.1016/j.jvs.2006.02.054
Taubert KA, Rowley AH, Shulman ST (1991) Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 119(2):279–282
Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131(6):888–893
Tremoulet AH, Best BM, Song S, Wang S, Corinaldesi E, Eichenfield JR, Martin DD, Newburger JW, Burns JC (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153(1):117–121. doi:10.1016/j.jpeds.2007.12.021
Tseng JF, Cambria RP, Aretz HT, Brewster DC (1999) Thoracoabdominal aortic aneurysm in Cogan’s syndrome. J Vasc Surg 30(3):565–568
Tsuda E, Kitamura S (2004) National survey of coronary artery bypass grafting for coronary stenosis caused by Kawasaki disease in Japan. Circulation 110(11 Suppl 1):II61–II66. doi:10.1161/01.CIR.0000138194.61225.10
Tsuda E, Kitamura S, Kimura K, Kobayashi J, Miyazaki S, Echigo S, Yagihara T (2007) Long-term patency of internal thoracic artery grafts for coronary artery stenosis due to Kawasaki disease: comparison of early with recent results in small children. Am Heart J 153(6):995–1000. doi:10.1016/j.ahj.2007.03.034
Ueda H, Ito I, Takeda T, Sugiura M, Saito Y (1968) Clinical observations of aortitis syndrome, with special reference to hypertension. Saishin Igaku 23(8):1730–1740
Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22(2):79–85
Unizony S, Stone JH, Stone JR (2013) New treatment strategies in large-vessel vasculitis. Curr Opin Rheumatol 25(1):3–9. doi:10.1097/BOR.0b013e32835b133a
Vaideeswar P, Deshpande JR (2013) Pathology of Takayasu arteritis: a brief review. Ann Pediatr Cardiol 6(1):52–58. doi:10.4103/0974-2069.107235 APC-6-52 [pii]
Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46(4):862–873
Voskuyl AE (2006) The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford) 45(Suppl 4):iv4–7. doi:10.1093/rheumatology/kel313
Vuran C, Simon P, Wollenek G (2010) Internal mammary artery grafting for coronary hypoperfusion in children. Thorac Cardiovasc Surg 58(6):359–360. doi:10.1055/s-0029-1240808
Wagner AD, Wittkop U, Prahst A, Schmidt WA, Gromnica-Ihle E, Vorpahl K, Hudson AP, Zeidler H (2003) Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis. Clin Exp Rheumatol 21(2):185–192
Watts RA, Lane SE, Scott DG, Koldingsnes W, Nossent H, Gonzalez-Gay MA, Garcia-Porrua C, Bentham GA (2001) Epidemiology of vasculitis in Europe. Ann Rheum Dis 60(12):1156–1157
Weidner N (2001) Giant-cell vasculitides. Semin Diagn Pathol 18(1):24–33
Weinstein RS (2011) Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 365(1):62–70. doi:10.1056/NEJMcp1012926
Weyand CM, Goronzy JJ (2002) Pathogenic mechanisms in giant cell arteritis. Cleve Clin J Med 69(Suppl 2):SII28–SII32
Weyand CM, Goronzy JJ (2003) Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139(6):505–515, 139/6/505 [pii]
Weyand CM, Ma-Krupa W, Pryshchep O, Groschel S, Bernardino R, Goronzy JJ (2005) Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci 1062:195–208. doi:10.1196/annals.1358.023, 1062/1/195 [pii]
Weyand CM, Liao YJ, Goronzy JJ (2012) The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol 32(3):259–265. doi:10.1097/WNO.0b013e318268aa9b 00041327-201209000-00017 [pii]
Weyn T, Haine S, Conraads V (2009) Cogan’s syndrome with left main coronary artery occlusion. Cardiol J 16(6):573–576
Yanagawa B, Kumar P, Tsuneyoshi H, Kachel E, Massad E, Moussa F, Cohen GN (2010) Coronary artery bypass in the context of polyarteritis nodosa. Ann Thorac Surg 89(2):623–625. doi:10.1016/j.athoracsur.2009.07.058
Yeung RS (2005) Pathogenesis and treatment of Kawasaki’s disease. Curr Opin Rheumatol 17(5):617–623
Yoshikawa Y, Yagihara T, Kameda Y, Taniguchi S, Tsuda E, Kawahira Y, Uemura H, Kitamura S (2000) Result of surgical treatments in patients with coronary-arterial obstructive disease after Kawasaki disease. Eur J Cardiothorac Surg 17(5):515–519
Yu JJ, Choi HS, Kim YB, Son JS, Kim YH, Ko JK, Park IS (2010) Analyses of left ventricular myocardial deformation by speckle-tracking imaging during the acute phase of Kawasaki disease. Pediatr Cardiol 31(6):807–812. doi:10.1007/s00246-010-9708-7
Yuce M, Davutoglu V, Sari I, Onat AM (2011) Polyarteritis nodosa with multiple coronary aneurysms presenting as acute myocardial infarction. Am J Med Sci 341(5):409. doi:10.1097/MAJ.0b013e3181e2e9d8
Zhu BH, Lv HT, Sun L, Zhang JM, Cao L, Jia HL, Yan WH, Shen YP (2012) A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease. Eur J Pediatr 171(3):571–578. doi:10.1007/s00431-011-1585-4
Zizic TM, Classen JN, Stevens MB (1982) Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med 73(4):525–531
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Dye, J.R., Kaul, M.S., St. Clair, E.W. (2014). Inflammatory Diseases of the Coronary Arteries. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37393-0_64-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-37393-0_64-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-37393-0
eBook Packages: Springer Reference MedicineReference Module Medicine